Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

BioRestorative Therapies (BRTX) Operating Margin (2016 - 2025)

Historic Operating Margin for BioRestorative Therapies (BRTX) over the last 15 years, with Q3 2025 value amounting to 31432.3%.

  • BioRestorative Therapies' Operating Margin fell 304532800.0% to 31432.3% in Q3 2025 from the same period last year, while for Sep 2025 it was 3785.07%, marking a year-over-year decrease of 5793100.0%. This contributed to the annual value of 2881.59% for FY2024, which is 75578900.0% up from last year.
  • Latest data reveals that BioRestorative Therapies reported Operating Margin of 31432.3% as of Q3 2025, which was down 304532800.0% from 1089.77% recorded in Q2 2025.
  • Over the past 5 years, BioRestorative Therapies' Operating Margin peaked at 979.02% during Q3 2024, and registered a low of 126537.95% during Q4 2022.
  • In the last 5 years, BioRestorative Therapies' Operating Margin had a median value of 16687.47% in 2023 and averaged 28300.69%.
  • Per our database at Business Quant, BioRestorative Therapies' Operating Margin tumbled by -804870200bps in 2021 and then skyrocketed by 1098504700bps in 2023.
  • Over the past 5 years, BioRestorative Therapies' Operating Margin (Quarter) stood at 80185.34% in 2021, then plummeted by -58bps to 126537.95% in 2022, then surged by 87bps to 16687.47% in 2023, then surged by 63bps to 6212.8% in 2024, then crashed by -406bps to 31432.3% in 2025.
  • Its Operating Margin stands at 31432.3% for Q3 2025, versus 1089.77% for Q2 2025 and 19230.14% for Q1 2025.